Search

everythinglearnresearchcommunity

for

Search:↓

Inhibiting TYK2 can restore hair growth in alopecia areata.

Loss of Ten1 in mice causes telomere shortening and symptoms similar to human dyskeratosis congenita.

Chronic T. gondii infection may harm male fertility.

Loss of TET2 increases the risk of skin and oral cancer.

Both penicillamine and tiopronin have significant side effects, but trying the alternative drug can be beneficial if the first is not tolerated.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

Deucravacitinib led to full hair regrowth in a severe alopecia areata patient.

Cell-mediated drug delivery systems improve skin disease treatment by using living cells for precise, prolonged, and less toxic therapy.

Some patients with severe alopecia areata developed skin darkening from their treatment, which may indicate a less effective response to the therapy.

Dexamethasone reduces inflammation and delays skin cell changes caused by TPA.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Blocking α-toxin helps heal Staphylococcus aureus-infected wounds faster in both normal and diabetic mice, with different effects on their immune responses.

The photolyase-based device significantly changed the size and heat of potential skin cancer areas in patients.

The CD4 protein may play a role in the behavior of certain skin cells, affecting their growth, movement, and differentiation.

DNA methylation of miR-365-1 causes hair follicle stem cell death by affecting DAP3.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Trichothiodystrophy hair is structurally abnormal with protein and organization issues.

The medicine Cyclosporin A might cause excessive hair growth by reducing a protein that controls hair growth.

TCDD reduces EGF receptor activity and causes various developmental changes in animals.

ODC expression in mouse skin and tumors is varied and can be inhibited by retinoic acid or cycloheximide.

Expanded CD8+ T cells are linked to Alopecia Areata and may cause relapse after treatment.

THAP1 gene changes do not affect DYT1 dystonia; finasteride may help reduce tics and OCD in Tourette syndrome.

Systemic photodynamic therapy can effectively treat stubborn folliculitis decalvans with few side effects.

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

A child with trichothiodystrophy also had autoimmune thyroiditis and anemia, which is a new finding.

T-cell reconstitution after thymus transplantation can cause hair whitening and loss.

2-deoxy D-glucose does not help with hair regrowth in alopecia areata.

Removing STAT5 from 3D-cultured human skin cells reduces their ability to grow hair.